NEW YORK (TheStreet) -- CHANGE IN RATINGSAsbury Automotive ABG downgraded at Craig-Hallum from Buy to Hold, Craig-Hallum said. Valuation call, based on a $38 price target. Allison Transmission ALSN downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $24 price target. Company lowered its guidance. Alexion ALXN downgraded at Lazard from Buy to Neutral, Lazard Capital Markets said. $102 price target. Stock appears attractive, following a 30% decline. AMN Healthcare Services AHS is upgraded to buy at TheStreet Ratings. Capital One COF downgraded at Guggenheim to Neutral, Guggenheim said. $59 price target. Recent trends will not support a multiple expansion. Deckers DECK downgraded at Wedbush from Outperform to Neutral, Wedbush said. Valuation call, based on a $45 price target. HollyFrontier HFC downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Valuation call. Starwood Hotels HOT downgraded at Jefferies to $66, Jefferies said. $66 price target. Valuation call. NVIDIA NVDA is upgraded to buy at TheStreet Ratings. QLogic QLGC is upgraded to buy at TheStreet Ratings. PNM Resources PNM upgraded at Baird from Neutral to Outperform, Robert Baird said. $24 price target. San Juan appears back on track, which should improve earnings visibility. SAIC SAI downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $12 price target. Valuation call, as the stock has outperformed its peers by 13% year-to-date. Sealed Air SEE downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $22.50 price target. Sealed Air downgraded at Wells from Market Perform to Underperform, Wells Fargo said. Company's cash generation is lagging. Sirona Dental SIRO downgraded at Baird from Outperform to Neutral, Robert Baird said. $76 price target. Sales of new products may not ramp as quickly as expected. Staples SPLS upgraded at Citigroup to Neutral from Sell, Citigroup said. $16 price target. Possible industry consolidation. Total System Services TSS downgraded at Jefferies to Hold from Buy, Jefferies said. $23 price target. Surprising NTSP acquisition. Visteon VC upgraded at JP Morgan to Overweight, JP Morgan said. Company is attractive on a sum-of-the-parts valuation. Minimum fair value of $73 price target. Windstream WIN downgraded at UBS to Sell from Neutral, UBS said. $7.50 price target. Dividend payout not sustainable.
STOCK COMMENTS / EPS CHANGESAnalog Devices ADI numbers increased at JP Morgan through 2014, JP Morgan said. Company boosted its guidance. Overweight rating and new $51 price target. Analog Devices target raised at Jefferies to $51, Jefferies said. Improving order rates. Hold rating. BJ's Restaurants BJRI numbers lowered at Oppenheimer. Shares of BJRI now seen reaching $38, Oppenheimer said. Estimates also lowered as model remains challenged. Outperform rating. Bruker BRKR numbers raised at UBS. Shares of BRKR now seen reaching $21, UBS said. Estimates also increased on double digit organic growth and EPS beat in 4Q. Buy rating. Conagra CAG estimates, target raised at Credit Suisse. Shares of CAG now seen reaching $36, according to Credit Suisse. Estimates also increased, as the company is carrying a lot of momentum into 2013. Neutral rating. Chemed Corporation CHE target raised at Oppenheimer to $91, Oppenheimer said. Fourth quarter beat. Outperform rating. Express Scripts ESRX numbers boosted at Lazard. Shares of ESRX now seen reaching $65, according to Lazard Capital Markets. Estimates also upped, given better operating trends. Buy rating. Express estimates, target boosted at Wedbush. Shares of EXPR now seen reaching $22, according to Wedbush. Estimates also upped, given positive early checks on the Spring season. Outperform rating. First Solar FSLR numbers raised at UBS. Shares of FSLR now seen reaching $36, UBS said. Estimates also increased on expected guide up for 2013 on higher margins. Neutral rating. Medtronic MDT estimates, target increased at BMO. MDT estimates were raised through 2015, BMO Capital said. Company continues to grow across the board. Outperform rating and new $52 price target. Omnicare OCR estimates, target upped at JP Morgan. OCR estimates were boosted through 2014, JP Morgan said. Company raised its guidance. Overweight rating and new $45 price target. Qualcomm QCOM added to Conviction Buy List at Nomura. QCOM was placed on the US Conviction Buy list, according to Nomura. Company is a market leader and should see improving traction in China. $75 price target. Realogy RLGY estimates, target raised at JP Morgan. Shares of RLGY now seen reaching $51, according to JP Morgan. Estimates also increased, given better business trends. Overweight rating. Sealed Air SEE numbers raised at Jefferies. Shares of SEE now seen reaching $25, Jefferies said. Estimates also raised on hard stance on pricing and restructuring underway. Buy rating. Tennant Company TNC target raised at Jefferies to $50, Jefferies said. Margin development and share repos look better. Hold rating. Vivus VVUS estimates, target reduced at JMP. Shares of VVUS now seen reaching $30, according to JMP Securities. Estimates also cut, given lower expected Qsymia sales. Outperform rating. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.